The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines
NCT03837561
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
136
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
Cunox
DRUG:
Botox
Sponsor
Medy-Tox